Grupo Italfarmaco (Portugal)

Grupo Italfarmaco (Portugal) is the Portuguese arm of the Italian pharmaceutical group Italfarmaco, which was founded in 1938 and is headquartered in Milan. The Portuguese operation was established in July 1999 and has since built a local presence focused on the development and commercialisation of pharmaceutical products and supplements. Its therapeutic areas include musculoskeletal health, among others, and it serves healthcare professionals across Portugal. The Portuguese subsidiary belongs to a wider international group that produces and markets ethical products and supplements in Italy, Switzerland, France, Spain, Germany, Portugal, Greece, Russia, Turkey, Chile, Peru, Morocco, and also for its subsidiary Chemi Spa in the United States and Brazil. The group employs more than 3,000 people and reports annual sales of over 800 million euros. Its industrial footprint includes manufacturing units in Milan (injectable and solid oral preparations), Madrid (liquid oral products), and chemical-pharmaceutical production in Frosinone (Italy), Camaçari (Brazil), and Malta. In Portugal, the company has been active for more than two decades. In 2017 it acquired a landmark 18th-century property, Quinta de Santo António in Algés, to serve as its Portuguese headquarters. The site, which historically featured five water sources fed by the Algés aquifer, now hosts the company's offices and the Academia Italfarmaco, a scientific training initiative launched in November 2018. The academy provides continuing education for healthcare professionals on topics such as nutrition and pregnancy, women's health, sleep, memory, respiratory system, and probiotics. The Portuguese operation positions itself around values of serving health, quality, scientific progress, and transparent and participatory management. It emphasises employee development, training, work-life balance, and equal opportunities. The company's local identity is closely tied to its parent group's international reach while maintaining a distinct Portuguese presence through its headquarters, academy, and therapeutic focus.

The Portuguese operation of Grupo Italfarmaco was founded in July 1999, marking the Italian group's entry into the Portuguese market. The parent company, Italfarmaco, had been established in 1938 in Milan and had grown into an international pharmaceutical group with operations across Europe, Latin America, and other regions. From its foundation, Italfarmaco Portugal defined its mission around serving health by developing and commercialising quality pharmaceutical products that represent scientific, technological, and economic progress. The company focused on ethical products and supplements, with therapeutic areas including musculoskeletal health. In 2017, the Portuguese subsidiary acquired a significant piece of real estate for its headquarters: the Quinta de Santo António in Algés. This 18th-century estate was one of several properties in Algés belonging to wealthy families and had historically been both an agricultural farm and a leisure space. A key feature of the property is its water system, which once ran through five fountains or spouts, all fed by the Algés aquifer, with origins possibly dating back to Arab and even Roman occupation. The estate also retains bicentennial tiles and the manor house of the former owners of the old Miraflores farm. In November 2018, the company launched the Academia Italfarmaco at its Algés headquarters. The academy was created to provide current scientific training useful for the daily clinical practice of healthcare professionals and of great interest to public health. Its courses and training sessions are held both at the group's facilities and at prestigious higher education institutions with which the group has partnerships. Topics covered include nutrition and pregnancy, women's health (including vaginal estrogen therapy in oncology patients and the Blissafe study), sleep and wakefulness (including the importance of prolonged-release melatonin), memory (healthy cognitive ageing, dementia prevention, and the role of DHA), respiratory system (viral infections and preventing COPD exacerbations), and probiotics (the role of synbiotics in intestinal flora balance in adults and children). The Portuguese operation is part of a group that today produces and markets products in Italy, Switzerland, France, Spain, Germany, Portugal, Greece, Russia, Turkey, Chile, Peru, Morocco, and for its subsidiary Chemi Spa in the USA and Brazil. The group has over 3,000 employees and annual sales exceeding 800 million euros. Its industrial production is divided into two main units: Milan, which produces injectable and solid oral preparations, and Madrid, which manufactures liquid oral products. Chemical-pharmaceutical products are manufactured in Frosinone (Italy), Camaçari (Brazil), and Malta. Throughout its history in Portugal, the company has emphasised values of participation, transparency, responsibility, initiative, commitment, autonomy, quality, development, efficiency, flexibility, agility, justice, coherence, equality, and goal achievement. It offers employees a transparent and participatory management style while expecting commitment, initiative, and responsibility in return, and promotes training, motivation, work-life balance, and equal opportunities.

• 2018

  Academia Italfarmaco launched in November at the Algés headquarters.

• 2017

  Acquisition of Quinta de Santo António in Algés for the Portuguese headquarters.

• 1999

  Italfarmaco Portugal founded in July.

• 1938

  Italfarmaco group founded in Milan, Italy.

Serving health through quality pharmaceutical products that represent scientific, technological and/or economic progress.

Product categories. Pharmaceutical products · Supplements · Ethical products

1. 1Grupo Italfarmaco Portugalitalfarmaco.pt
2. 2Quinta de Sto Antonioitalfarmaco.pt
3. 3Trabalhar no Italfarmaco | Italfarmaco Portugalitalfarmaco.pt
4. 4Academia Italfarmaco | Italfarmaco Portugalitalfarmaco.pt
5. 5Grupo Italfarmaco (Portugal) - Wikidatawikidata.org